BIOINFRA Life Science

Innovative Technology for Wellness and Prevention

Read more

We lead a new paradigm in healthcare that spans treatment and disease prevention.

BIOINFRA Life Science is a global healthcare company that provides leadership, with innovative solutions, in the bio-industry and the field of human health.

We are ahead in the industry with our 15 years of accumulated research and world-class technology.

BIOINFRA Life Science’s innovations will continue with effective cancer prevention technologies that make happy and healthy lives a reality.

Approximately 8.2 million people die from cancer worldwide every year.

5-Year Cancer Survival Rate
Average of all cancers
  • Lung cancer 25%
  • Liver cancer 33%
  • Stomach cancer 74%
  • Colorectal cancer 76%
  • Prostate cancer 93%
  • Breast cancer 92%
  • Pancreatic cancer 10%
  • Ovarian cancer 64%

National Cancer Information Center, Trend of 5-Year Relative Survival Rate for Major Cancers in Korea (2010-2014)

The most effective way to combat cancer is prevention and swift treatment through early detection.

5-Year Survival Rate with Early Cancer Detection
Average of all cancers
  • Lung cancer 61%
  • Liver cancer 53%
  • Stomach cancer 96%
  • Colorectal cancer 96%
  • Prostate cancer 100%
  • Breast cancer 98%
  • Pancreatic cancer 33%
  • Ovarian cancer 92%

National Cancer Information Center, Trend of 5-Year Relative Survival Rate for Major Cancers Per Summary Stage in Korea (2010-2014)

Multi-Biomarker Blood Test

The multi-biomarker blood test, developed through more than 15 years of our research, is a world class cancer screening technology that analyzes the risk of 8 major cancers with a small amount of blood.

  • Lung Cancer
  • Liver Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Ovarian Cancer


Daehak-ro 49, 7F, Jongno-gu, Seoul 03127


Cancer Research Institute, Seoul National University, 101 Daehak-ro 8F, Jongno-gu, Seoul 03080

오늘하루 열지않음